Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patient-prosthesis mismatch in aortic valve replacement: really tolerable?

Rafael García Fuster1, José A Montero Argudo, Oscar Gil Albarova

  • 1Universitary General Hospital of Valencia, Av. Tres Cruces s/n, C/ Artes Gráficas no. 4, esc. izq. pta. 3, 46014 Valencia, Spain. rgfuster@terra.com

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|March 3, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification.

Clinical cardiology·2025
Same author

Determination of calcium and parathyroid hormone levels following hemithyroidectomy.

Thyroid research·2021
Same author

Single Low-Volume Center Experience with Frozen Elephant Trunk in Acute Type A Aortic Dissections.

Aorta (Stamford, Conn.)·2019
Same author

Epidemiology of Cardiac Myxoma in a Spanish Population. A 30-year Surgical Series.

Revista espanola de cardiologia (English ed.)·2018
Same author

Perceval Less Invasive Aortic Replacement Register: multicentric Spanish experience with the Perceval S bioprosthesis in moderate-high-risk aortic surgery.

Interactive cardiovascular and thoracic surgery·2017
Same author

Comments on the ESC guidelines on the management of valvular heart disease (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.

Revista espanola de cardiologia (English ed.)·2014

Patient-prosthesis mismatch after aortic valve replacement can lead to impaired left ventricular mass regression and increased mortality, especially in patients with severe hypertrophy. Avoiding mismatch is crucial for better outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomedical Engineering

Background:

  • Patient-prosthesis mismatch (PPM) after aortic valve replacement (AVR) is a concern.
  • Third-generation prostheses have shown favorable results despite PPM.
  • The long-term tolerability of PPM remains under investigation.

Purpose of the Study:

  • To determine if patient-prosthesis mismatch is always tolerable after aortic valve replacement.
  • To analyze the impact of PPM on left ventricular mass regression and in-hospital outcomes.
  • To evaluate the influence of preoperative left ventricular mass on mortality in the context of PPM.

Main Methods:

  • A clinical-echocardiographic study of 339 patients undergoing AVR for aortic stenosis.
  • Analysis of in-hospital outcomes and left ventricular mass index regression (1 month-1 year).

Related Experiment Videos

  • Comparison between patients with and without PPM (indexed effective orifice area <= 0.85 cm²/m²).

    • Main Results:

    • PPM was present in 38% of patients.
    • Mass regression was impaired in patients with PPM, particularly those with increased preoperative left ventricular mass.
    • In the presence of PPM, increased ventricular mass was associated with significantly higher mortality (14.7% vs 2.1%).

    Conclusions:

    • Eluding patient-prosthesis mismatch is important in severe ventricular hypertrophy to reduce mortality and improve mass regression.
    • Mismatch may be tolerable in patients with less severe left ventricular hypertrophy.
    • Optimizing prosthesis selection is key to mitigate PPM complications.